FDMT
4d Molecular Therapeutics, Inc.
Clinical-stage gene therapy company
CUSIP: 35104E100HealthcareUS1 holder
Total Value
$86.52M
Total Shares
4.79M
Net Share Change
+850.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$86.52M4.79M shares
ADD+850.0K(+21.6%)